Contributing Editors
-
Why FAT Should Confirm Alignment, Not Reveal Its Absence
6/1/2026
In many aseptic fill/finish projects, the factory acceptance test (FAT) has become the first true integration test of the entire project. That is a problem. Here's how to flip that mindset.
-
What Reliance, Annex 1, And AI Mean For The Future Of GMP
5/29/2026
EMA’s Brendan Cuddy explains how regulators are adapting oversight to global supply chains, new technologies, and growing operational complexity.
-
Applying Contamination Control By Design: A Practical Guide For CDMOs
5/26/2026
This article addresses the three contamination control challenges that are specific to the CDMO environment, provides five practical steps any organization can act on now, and more.
-
Field Notes: Freeing Process Data For Automation At Kivi Bio AI Summit
5/22/2026
The missing link between data generation and unleashing it to power automation often lies in well-governed cloud infrastructure.
-
Rethinking CQV In A Digital, Agile Manufacturing Landscape
5/21/2026
While commissioning, qualification, and validation (CQV) remains foundational, the way it is planned and executed must evolve to keep pace with modern manufacturing realities.
-
Will FDA's One-Day Inspection Pilot Stand The Test Of Time?
5/19/2026
FDA's complementary pilot could help weed through a persistent examination backlog, but uncertainty and upheaval in leadership at the top puts its future in question.
-
A Multi-Agent Audit Intelligence Framework For CDMO Quality Oversight
5/18/2026
A Takeda quality executive demonstrates how a team of AI agents uses synthetic data to provide decision support ahead of CDMO audits.
-
Why Contamination Control By Design Should Matter To Your CDMO
5/18/2026
EU GMP Annex 1 mandates a documented contamination control strategy, and FDA expectations are substantively equivalent. Let's look at why CDMOs are disproportionately exposed.
-
Closing The MES Value Gap: Why Technology Isn't The Problem
5/14/2026
Manufacturing execution system (MES) technical maturity is rising, but adoption across manufacturing sites is uneven. Organizational readiness may hold the key.
-
Why Isolators Do Not Automatically Ensure Annex 1 Compliance
5/12/2026
Isolators are powerful tools, but they do not automatically ensure compliance with EU GMP Annex 1. RABS are frequently dismissed too quickly. The difference is not the technology itself, but how it is applied.